p53 Expression as a Prognostic Indicator of 5-Year Survival in Endometrial Cancer

By Geisler J.P.   Geisler H.E.   Wiemann M.C.   Zhou Z.   Miller G.A.   Crabtree W.  

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 468-471

Elsevier

Access to resources Recommend Favorite

Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer

By Mathew R.   Arora S.   Khanna R.   Mathur M.   Shukla N.K.   Ralhan R.  

European Journal of Cancer, Vol. 38, Iss. 6, 2002-01 ,pp. : 832-841

Elsevier

Access to resources Recommend Favorite

p53 Protein Overexpression in Early Stage Endometrial Cancer

By Kohlberger P.   Gitsch G.   Loesch A.   Tempfer C.   Kaider A.   Reinthaller A.   Kainz C.   Breitenecker G.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 213-217

Academic Press

Access to resources Recommend Favorite

Bax, Bcl-2, and p53 Expression in Endometrial Cancer

By Sakuragi N.   Salah-eldin A-e.   Watari H.   Itoh T.   Inoue S.   Moriuchi T.   Fujimoto S.  

Gynecologic Oncology, Vol. 86, Iss. 3, 2002-09 ,pp. : 288-296

Academic Press

Access to resources Recommend Favorite

p53 Interference and Growth Inhibition in p53-Mutant and Overexpressing Endometrial Cancer Cell Lines

By Janicek M.F.   Angioli R.   Unal A.D.   Sevin B.-U.   Madrigal M.   Estape R.   Averette H.E.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 94-102

Elsevier

Access to resources Recommend Favorite